跳至主要内容
临床试验/NL-OMON53565
NL-OMON53565招募中2 期

Addition of a Focal boost In external beam Radiotherapy for locally advanced prostate cancer by online adaptive MR-guided radiotherapy (AFFIRM trial) - AFFIRM trial

Radboud Universitair Medisch Centrum0 个研究点目标入组 95 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
95

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Men aged 18 years or older with histogically proven prostate carcinoma
  • Imaging stage T3b (as defined on mpMRI) N0M0
  • Intraprostatic lesion visible on MRI
  • Capable of giving informed consent
  • Participation in the MOMENTUM dataregistry

排除标准

  • History of radiotherapy to the pelvis or transurethral resection of the
  • prostate (TURP)
  • Contraindications for MRI according to the guidelines of the Department of
  • Radiology, inability to lay on a treatment table for 45-60 minutes or severe
  • claustrophobia
  • Absence of pretreatment PSMA PET CT
  • WHO performance score > 2
  • International Prostate Symptom Score >= 15
  • Prostate volume >100cc

研究者

相似试验